Decreases in peripheral-type benzodiazepine receptors in postmortem brains of chronic schizophrenics - PubMed (original) (raw)
. 1997;104(11-12):1361-70.
doi: 10.1007/BF01294737.
Affiliations
- PMID: 9503282
- DOI: 10.1007/BF01294737
Decreases in peripheral-type benzodiazepine receptors in postmortem brains of chronic schizophrenics
A Kurumaji et al. J Neural Transm (Vienna). 1997.
Abstract
We measured the peripheral-type benzodiazepine receptors (PBRs), a marker of gliosis, in 26 brain areas (cerebral cortex, thalamus and extrapyramidal system) of the postmortem brains of 13 chronic schizophrenics and 10 controls, using [3H] PK 11195 as a ligand for the receptor assay. The specific [3H] PK 11195 binding was significantly decreased in three brain areas (superior parietal cortex, primary visual area and putamen) of schizophrenics, although there were no changes in the binding in the other brain areas. Scatchard analysis revealed that there were decreases in both the Bmax and Kd of [3H] PK 11195 binding in the brain areas. These results were almost in accordance with a number of neuropathological studies reporting that there was no change or reduction in glial cells in the brain regions of schizophrenics and suggested that the decreased density of PBRs in the brain may be involved in the pathophysiology of schizophrenia, associated with reduced production of neurosteroids coupled to PBRs.
Similar articles
- Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics.
Kiuchi Y, Kobayashi T, Takeuchi J, Shimizu H, Ogata H, Toru M. Kiuchi Y, et al. Eur Arch Psychiatry Neurol Sci. 1989;239(2):71-8. doi: 10.1007/BF01759578. Eur Arch Psychiatry Neurol Sci. 1989. PMID: 2553417 - A postmortem study of glycine and its potential precursors in chronic schizophrenics.
Kurumaji A, Watanabe A, Kumashiro S, Semba J, Toru M. Kurumaji A, et al. Neurochem Int. 1996 Sep;29(3):239-45. doi: 10.1016/0197-0186(96)00013-7. Neurochem Int. 1996. PMID: 8885282 - Peripheral-type benzodiazepine-binding sites in platelets of schizophrenics with and without tardive dyskinesia.
Weizman R, Tanne Z, Karp L, Tyano S, Gavish M. Weizman R, et al. Life Sci. 1986 Aug 11;39(6):549-55. doi: 10.1016/0024-3205(86)90512-6. Life Sci. 1986. PMID: 3016444 - The role of peripheral benzodiazepine receptors (PBRs) in CNS pathophysiology.
Lang S. Lang S. Curr Med Chem. 2002 Aug;9(15):1411-5. doi: 10.2174/0929867023369745. Curr Med Chem. 2002. PMID: 12173979 Review. - Decreased Brain pH and Pathophysiology in Schizophrenia.
Park HJ, Choi I, Leem KH. Park HJ, et al. Int J Mol Sci. 2021 Aug 4;22(16):8358. doi: 10.3390/ijms22168358. Int J Mol Sci. 2021. PMID: 34445065 Free PMC article. Review.
Cited by
- Inflammatory Subtypes in Antipsychotic-Naïve First-Episode Schizophrenia are Associated with Altered Brain Morphology and Topological Organization.
Hoang D, Xu Y, Lutz O, Bannai D, Zeng V, Bishop JR, Keshavan M, Lizano P. Hoang D, et al. Brain Behav Immun. 2022 Feb;100:297-308. doi: 10.1016/j.bbi.2021.11.019. Epub 2021 Dec 4. Brain Behav Immun. 2022. PMID: 34875344 Free PMC article. - Actualities in immunological markers and electrochemical sensors for determination of dopamine and its metabolites in psychotic disorders (Review).
Ciobanu AM, Geza L, David IG, Popa DE, Buleandra M, Ciucu AA, Dehelean L. Ciobanu AM, et al. Exp Ther Med. 2021 Aug;22(2):888. doi: 10.3892/etm.2021.10320. Epub 2021 Jun 17. Exp Ther Med. 2021. PMID: 34194566 Free PMC article. Review. - Concentration, distribution, and influence of aging on the 18 kDa translocator protein in human brain: Implications for brain imaging studies.
Tong J, Williams B, Rusjan PM, Mizrahi R, Lacapère JJ, McCluskey T, Furukawa Y, Guttman M, Ang LC, Boileau I, Meyer JH, Kish SJ. Tong J, et al. J Cereb Blood Flow Metab. 2020 May;40(5):1061-1076. doi: 10.1177/0271678X19858003. Epub 2019 Jun 20. J Cereb Blood Flow Metab. 2020. PMID: 31220997 Free PMC article. - Activation of IL-8 and its participation in cancer in schizophrenia patients: new evidence for the autoimmune hypothesis of schizophrenia.
Xu L, Qi X, Zhu C, Wan L. Xu L, et al. Neuropsychiatr Dis Treat. 2018 Dec 13;14:3393-3403. doi: 10.2147/NDT.S188210. eCollection 2018. Neuropsychiatr Dis Treat. 2018. PMID: 30587991 Free PMC article. - TSPO in diverse CNS pathologies and psychiatric disease: A critical review and a way forward.
Guilarte TR. Guilarte TR. Pharmacol Ther. 2019 Feb;194:44-58. doi: 10.1016/j.pharmthera.2018.09.003. Epub 2018 Sep 4. Pharmacol Ther. 2019. PMID: 30189290 Free PMC article. Review.
References
- Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):5113-7 - PubMed
- Acta Psychiatr Scand. 1988 Aug;78(2):121-37 - PubMed
- Neuropharmacology. 1996;35(8):1075-9 - PubMed
- Eur Arch Psychiatry Neurol Sci. 1986;236(3):154-61 - PubMed
- Brain Res. 1987 Sep 22;421(1-2):167-72 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical